Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
Farmers Insurance
Cerilliant
Chinese Patent Office
Express Scripts
Colorcon
McKinsey
AstraZeneca
Cantor Fitzgerald

Generated: February 25, 2018

DrugPatentWatch Database Preview

Midazolam hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for midazolam hydrochloride and what is the scope of midazolam hydrochloride freedom to operate?

Midazolam hydrochloride
is the generic ingredient in four branded drugs marketed by Akorn Inc, Apothecon, Baxter Hlthcare Corp, Bedford, Ben Venue, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Hospira Inc, Igi Labs Inc, Intl Medicated, Intl Medication, West-ward Pharms Int, Wockhardt, Mylan Asi, Sagent Strides, HLR, Apotex Inc, Hi Tech Pharma, Paddock Llc, Sun Pharm Inds Ltd, and Roche, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for midazolam hydrochloride. Twenty-three suppliers are listed for this compound. There are three tentative approvals for this compound.
Pharmacology for midazolam hydrochloride
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for midazolam hydrochloride
Tentative approvals for MIDAZOLAM HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign UpEQ 5MG BASE/MLINJECTABLE;INJECTION
➤ Sign Up➤ Sign UpEQ 5MG BASE/MLINJECTABLE;INJECTION
➤ Sign Up➤ Sign UpEQ 5MG BASE/MLINJECTABLE;INJECTION

US Patents and Regulatory Information for midazolam hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075154-002 Jun 20, 2000 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare Corp MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075637-002 Oct 31, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075409-001 Jun 20, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075856-001 Jun 13, 2002 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075421-002 Jun 20, 2000 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075409-002 Jun 20, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Intl Medicated MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 076144-002 Jan 26, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075324-002 Jun 20, 2000 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075247-001 Jun 23, 2000 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075324-001 Jun 20, 2000 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for midazolam hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hlr VERSED midazolam hydrochloride INJECTABLE;INJECTION 018654-002 May 26, 1987 ➤ Sign Up ➤ Sign Up
Hlr VERSED midazolam hydrochloride INJECTABLE;INJECTION 018654-001 Dec 20, 1985 ➤ Sign Up ➤ Sign Up
Roche VERSED midazolam hydrochloride SYRUP;ORAL 020942-001 Oct 15, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
UBS
US Department of Justice
Julphar
McKesson
US Army
Harvard Business School
Cantor Fitzgerald
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot